Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer

Authors

Silvia Novello, University of Turin
Giorgio V. Scagliotti, University of Turin
Rafael C. Rosell, Catalan Institute of Oncology
Mark A. Socinski, University of North Carolina at Chapel Hill
Julie R. Brahmer, Sidney Kimmel Comprehensive Cancer Center
James N. Atkins, Southeastern Medical Oncology Center
Cinta Palleres, Hospital de San Pablo
Russell E. Burgess, Eastern Carolina Internal Medicine
Lesley Tye, Pfizer Global Research and Development
Paulina Selaru, Pfizer Global Research and Development
Erjian Wang, Pfizer Global Research and Development
Richard Chao, Pfizer Global Research and Development
Ramaswamy Govindan, Washington University School of Medicine in St. Louis

Journal

British Journal of Cancer

Publication Date

2009

Volume

101

Issue

9

Inclusive Pages

1543-1548

Document Type

Open Access Publication

DOI

10.1038/sj.bjc.6605346

Rights and Permissions

S Novello, et al. Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer. British Journal of Cancer (2009) 101, 1543–1548. doi:10.1038/sj.bjc.6605346 www.bjcancer.com Copyright 2009 Cancer Research UK From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ 16 November 2011 This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

Recommended Citation

Novello, Silvia; Scagliotti, Giorgio V.; Rosell, Rafael C.; Socinski, Mark A.; Brahmer, Julie R.; Atkins, James N.; Palleres, Cinta; Burgess, Russell E.; Tye, Lesley; Selaru, Paulina; Wang, Erjian; Chao, Richard; and Govindan, Ramaswamy, "Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer." British Journal of Cancer. 101, 9. 1543-1548. (2009).
https://digitalcommons.wustl.edu/open_access_pubs/4069